煙草在線據NACS報道編譯　　3月6日，美國食品與藥品監督管理局（FDA）的零售商研討會僅僅討論了小型業主提出的關于FDA煙草法規的一些最常見問題。該次會議并未披露任何新的信息，僅簡單重申了煙草零售商的法律義務。以下是研討會內容概覽：

　　·廣告：卷煙廣告不能包含“淡味”、“超淡味”等形容詞描述，且必須包含衛生部的健康警示內容。

　　·圖片警語標簽：根據2月底訴訟法庭的裁決，FDA要求卷煙包裝印刷圖片警語的規定是違憲的，在訴訟作出最終裁決前并不期望煙草零售商和制造商們執行此規定。

　　·免費樣品：零售商不能提供卷煙的免費樣品，而無煙煙草產品的免費樣品僅允許在禁止18歲以下青少年進入的店鋪中提供。

　　·贈品：除卷煙或無煙煙草產品打折出售外，零售商禁止向購買卷煙或無煙煙草產品者提供任何贈品或優惠（免費火柴除外）。同時，零售商不得向非煙草產品購買者（例如汽油購買者）提供任何卷煙或無煙煙草產品的打折優惠。FDA向全國大學商店協會（NACS）指出，消費者或許會通過購買卷煙或無煙煙草產品要求記錄其“忠誠度”，但零售商不能以任何“忠誠度累計”或類似的項目記錄消費者購買卷煙或無煙煙草產品的次數。

　　·電子卷煙：去年對于電子卷煙并非“藥品或醫藥設備”因此不遵守這些產品嚴格的法律措施的此法裁決，盡管FDA沒有提起上訴，但是FDA仍然有權對電子卷煙制定與卷煙產品類似的法律法規，也不排除將來出臺此類法規的可能性。

　　FDA并未宣布下一次煙草零售商研討會召開的時間和地點。您若錯過了3月6日的研討會，可以在FDA網站觀看在線視頻。

　　如果您想了解更多關于FDA民事賠償程序，或零售商的職責及遵守要求等內容，請注冊參加3月14日由NACS和We Card主辦的研討會。

FDA Reiterates Tobacco Retailers' Obligations

NACS
Mar 7, 2012

　　The Food and Drug Administration (FDA) webinar for retailers reviewed some of the most frequently asked questions small businesses have asked regarding FDA's tobacco regulations. The March 6 webinar did not reveal any new information, but simply reiterated tobacco retailers' legal obligations. Here is an overview:

　　·Advertisements: Cigarette advertisements may not include descriptors ("light," "ultra-light," etc.) and must include the Surgeon General's warning.

　　·Graphic warning labels: In light of last week's litigation court ruling that FDA's requirements for graphic warning labels on cigarette packages were unconstitutional, tobacco retailers and manufacturers are not expected to comply with that rule's mandates during the pending litigation.

　　·Free Samples: Retailer may not distribute free samples of cigarettes, and free samples of smokeless tobacco may only be distributed in facilities where minors under the age of 18 are not permitted to enter.

　　·Gifts: Retailers are prohibited from offering any benefit to a customer in return for purchasing cigarettes or smokeless tobacco (except for free matches) unless that benefit is discounted cigarettes or smokeless tobacco. Also, retailers may not offer discounted cigarettes or smokeless tobacco in return for any non-tobacco purchase (such as gasoline). FDA has indicated to NACS, however, that customers may redeem "loyalty points" by buying cigarettes or smokeless tobacco, but retailers may not count purchases of cigarettes or smokeless tobacco as points in any such loyalty or affinity program.

　　·E-Cigarettes: Although FDA did not appeal last year's judicial ruling that e-cigarettes are not "drugs or devices" and thus not subject to those products' strict regulatory treatment, FDA indicated that it has the authority to issue regulations regulating e-cigarettes as cigarettes, and that it may propose such regulations in the future.

　　FDA has not announced when its next tobacco compliance webinar for retailers will take place. If you missed the March 6 webinar, it is online.

　　If you want to learn more about how to navigate FDA's Civil Monetary Penalty Process and better understand retailer responsibilities and compliance requirements, register for the free March 14 webinar sponsored by NACS and We Card.